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Aims: Data from our group confirms that increased expression of Connexin-26 and Connexin-43 in 
biopsy material from patients with proven nephropathy is paralleled by TGF-b1-evoked changes in 
hemichannel-mediated ATP release. With recent studies linking increased ATP to fibrosis in multiple 
tissue types, we have previously confirmed that incubation of proximal tubule cells with ATPgS (1-
100µM) evokes increased expression of ECM markers. In the current study, we provide evidence of a 
direct role for ATP and associated downstream purinergic signalling as a mediator of TGF-b1 induced 
altered hemichannel activity in ECM expression. 
 
Methods: Human kidney (HK2) proximal tubule cells were treated for 48hrs with either TGF-
β1(10ng/mL) ± nucleotidase; apyrase (100µM) or ATPγS (10µM) ± purinergic receptor antagonist 
suramin (100µM). Expression of Collagen I, Collagen IV, Fibronectin and Laminin were determined by 
immunoblotting. 
 
Results: Immunoblotting confirmed that apyrase negated TGF-β1 upregulation of Collagen I, from 
366.0±13.0% of control to 119.5% (n=3 P<0.001) and reversed loss of Collagen IV expression from 
30.1±12.1% of control to 123.3±9.8% (n=3 P<0.01). The nucleotidase also negated an upregulation of 
Fibronectin, from 201.5±3.7% to 156.7±27.6% (n=3 P<0.01) and Laminin, from 339.5±43.1% to 
173.4±42.8% (n=3 P<0.05). Suramin inhibited ATPγS-induced changes in expression of ECM, 
reducing expression of Collagen I from 452.9±20.6% of control to 192.1±16.0%; Collagen IV from 
157.2±17.4% to 93.6±12.8%; Fibronectin from 222.6±9.5% to 103.7±5.2% and Laminin from 
177.8±25.0% to 86.4±11.7% (n=3 P<0.05). 
  
Conclusions: The current study confirms that TGF-b1 induced changes in hemichannel mediated 
ATP release may in part, contribute to tubular fibrosis in the diabetic kidney. 
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